) 268 (251sirtuininhibitor86) five.0 (four.6sirtuininhibitor.4) 7.4 (7.0sirtuininhibitor.9) 4.5 (four.3sirtuininhibitor.six) six.5 (6.4sirtuininhibitor.6) 2.9 (2.8sirtuininhibitor.0) 19.9 (15.4sirtuininhibitor56.8 (45.7sirtuininhibitor110.5 (96.8sirtuininhibitor88 (68sirtuininhibitor11) 251 (202sirtuininhibitor
) 268 (251sirtuininhibitor86) five.0 (4.6sirtuininhibitor.4) 7.4 (7.0sirtuininhibitor.9) four.5 (four.3sirtuininhibitor.six) 6.five (6.4sirtuininhibitor.six) 2.9 (two.8sirtuininhibitor.0) 19.9 (15.4sirtuininhibitor56.8 (45.7sirtuininhibitor110.5 (96.8sirtuininhibitor88 (68sirtuininhibitor11) 251 (202sirtuininhibitor04) 488 (428sirtuininhibitor57) 3.2 (2.8sirtuininhibitor.six) 9.2 (eight.3sirtuininhibitor0.0) 17.9 (16.8sirtuininhibitor8.9) five.0 (five.0sirtuininhibitor.1) 1.three (1.2sirtuininhibitor.3) 2.two (1.8sirtuininhibitor.six) four.1 (3.3sirtuininhibitor.0) 2.two (1.9sirtuininhibitor.five) 126 (101sirtuininhibitor51) 238 (191sirtuininhibitor86) 128 (110sirtuininhibitor46) 5.eight (five.3sirtuininhibitor.four) ten.9 (10.0sirtuininhibitor1.9) five.9 (five.5sirtuininhibitor.3)Total CHDPopulationDeaths(Millions)(Thousands)RegionalAustralasiaCanada andUnited StatesEast/CentralEurasiaWang et alEast/SoutheastAsiaLatin America/CaribbeanNorth Africa/Middle EastSouth AsiaSub-SaharanAfricaWesternEuropeList of nations within each region: Australasia: Australia, New Zealand; Canada and Usa: Canada, United states; East/Central Eurasia: Albania, Armenia, Azerbaijan, Bulgaria, Bosnia and Herzegovina, Belarus, Czech Republic, Estonia, Georgia, Croatia, Neuregulin-4/NRG4 Protein manufacturer Hungary, Kazakhstan, Kyrgyzstan, Lithuania, Latvia, Moldova, Macedonia, Montenegro, Mongolia, Poland, Romania, Russian Federation, Serbia, Slovakia, Slovenia, Tajikistan, Turkmenistan, Ukraine, Uzbekistan; East/ Southeast Asia: Darussalam, China, Fiji, Micronesia, Indonesia, Cambodia, Kiribati, Republic of Korea, Lao People’s Democratic Republic, Sri Lanka, Maldives, Marshall Islands, Myanmar, Malaysia, Philippines, Papua New Guinea, Solomon Islands, Thailand, Timor-Leste, Tonga, Taiwan, Vietnam, Vanuatu, Samoa, Brunei, Japan, Democratic People’s Republic of Korea, Singapore; Latin America/Caribbean: Argentina, Antigua and Barbuda, Bahamas, Belize, Bolivia, Brazil, Barbados, Chile, Colombia, Costa Rica, Cuba, Dominica, Dominican Republic, Ecuador, Grenada, Guatemala, Guyana, Honduras, Haiti, Jamaica, Saint Lucia, Mexico, Nicaragua, Panama, Peru, Paraguay, El Salvador, Suriname, Trinidad and Tobago, Uruguay, Saint Vincent and the Grenadines, Venezuela; North Africa/Middle East: United Arab Emirates, Bahrain, Algeria, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libyan Arab Jamahiriya, Morocco, Oman, Occupied Palestinian Territory, Qatar, Saudi Arabia, Syrian Arab Republic, Tunisia, Turkey, Yemen; South Asia: Bangladesh, Bhutan, India, Nepal, Pakistan; sub-Saharan Africa: Angola, Burundi, Benin, Burkina Faso, Botswana, Central African Republic, C^te d’Ivoire, o Cameroon, Democratic republic in the Congo, Congo, Comoros, Cape Verde, Djibouti, Eritrea, Ethiopia, Gabon, Ghana, Guinea, Gambia, IL-13, Cynomolgus (HEK293) Guinea-Bissau, Equatorial Guinea, Kenya, Liberia, Lesotho, Madagascar, Mali, Mozambique, Mauritania, Mauritius, Malawi, Namibia, Niger, Nigeria, Rwanda, Sudan, Senegal, Sierra Leone, Somalia, S o Tom and Pr a e incipe, Swaziland, Seychelles, Chad, Togo, United Republic of Tanzania, Uganda, South Africa, Zambia, Zimbabwe; Western Europe: Andorra, Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Iceland, Israel, Italy, Luxembourg, Malta, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Uk. E indicates percentage of total power intake; CHD, ischemic heart disease; n-6 PUFA, x-6 polyunsaturated fat; SFA, saturated fat; TFA, trans fat; UI, uncertainly interval. Imply national consumption levels among adults, (95 UI) ba.
